Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MDMA ('Ecstasy')”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 0 results

Very early researchStudy completedNCT05379959
What this trial is testing

Effects of Stimulants on Behavioral and Neural Markers of Social Motivation, Ability, and Neural Markers of Social Function

Who this might be right for
Stimulant UseMDMA ('Ecstasy')Social Behavior+1 more
University of Chicago 43
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07704762
What this trial is testing

Clinical Trial of MDMA-Assisted Therapy for Military Service Members With Posttraumatic Stress Disorder

Who this might be right for
PTSDPost Traumatic Stress Disorder PTSDPost Traumatic Stress Disorder
U.S. Army Medical Research and Development Command 86
Early research (Phase 1)Looking for participantsNCT06989957
What this trial is testing

Psilocybin and Methylenedioxymethamphetamine (MDMA) for Post-traumatic Stress Disorder (PTSD)

Who this might be right for
Posttraumatic Stress Disorder
Johns Hopkins University 40
Not applicableStudy completedNCT02342366
What this trial is testing

Characterization of the Prosocial and Prosexual Effects of GHB

Who this might be right for
Depressive Disorder, MajorBipolar DisorderAutistic Disorder
University of Zurich 19
Not applicableStudy completedNCT04648137
What this trial is testing

Circulating Oxytocin Changes in Response to the Oxytocin System Stimulator MDMA in Patients With Diabetes Insipidus and Healthy Controls

Who this might be right for
Diabetes Insipidus
University Hospital, Basel, Switzerland 30
Early research (Phase 1)Study completedNCT03181763
What this trial is testing

Evaluation of MDMA on Startle Response

Who this might be right for
Startle Response
Resilient Pharmaceuticals 34
Testing effectiveness (Phase 2)Looking for participantsNCT07288151
What this trial is testing

MDMA-Assisted Massed Exposure Therapy for PTSD

Who this might be right for
Post Traumatic Stress Disorder
Emory University 200
Early research (Phase 1)Active Not RecruitingNCT07584720
What this trial is testing

Study of Midomafetamine in Healthy Adults

Who this might be right for
Healthy Volunteers
Resilient Pharmaceuticals 32
Early research (Phase 1)Study completedNCT05809271
What this trial is testing

Acute Effects of 3,4-methylenedioxymethamphetamine (MDMA) With and Without a Booster Dose

Who this might be right for
Healthy
University Hospital, Basel, Switzerland 25
Large-scale testing (Phase 3)Looking for participantsNCT06394284
What this trial is testing

Examining 3,4-methylenedioxymethamphetamine (MDMA) Effects on Psychological, Relational and Hyperarousal-Related Neural Reactivity Mechanisms in Veterans With PTSD and Moral Injury

Who this might be right for
PTSD, Post Traumatic Stress DisorderMoral Injury
Herzog Hospital 60
Testing effectiveness (Phase 2)Study completedNCT02427568
What this trial is testing

MDMA-Assisted Psychotherapy for Anxiety Associated With a Life-Threatening Illness

Who this might be right for
Anxiety
Resilient Pharmaceuticals 18
Testing effectiveness (Phase 2)Looking for participantsNCT07301632
What this trial is testing

Ecstasy to Alleviate SEvere Chronic Neuropathic Pain Trial

Who this might be right for
Chronic Neuropathic Pain
Unity Health Toronto 50
Early research (Phase 1)WithdrawnNCT04073433
What this trial is testing

Psychological Effects of Methylenedioxymethamphetamine (MDMA) When Administered to Healthy Volunteers (MT-2)

Who this might be right for
Psychological Effects of Study Drug
Resilient Pharmaceuticals